Vivodyne
PrivateLast Round
Series A
May 29, 2025
Total Funding Raised
$82M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Vivodyne is a biotechnology company that develops a microfluidic bioengineering platform for advancing single-cell 4D phenomics and facilitating drug discovery and cellular therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Biotech Equipment
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivodyne Comparables
Compare Vivodyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quris AI | 86% | |
| Emulate | 85% | |
| Hesperos Inc. | 85% | |
Vivodyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 29, 2025 | ||||
| Seed | Nov 22, 2023 | ||||
| Seed | Mar 30, 2021 |
Key People
Founding team and executive leadership
Vivodyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Lingotto | Series A |
| Khosla Ventures | Series A, Seed |
| Kairos Ventures | Series A, Seed |
| Helena Capital | Series A |
| Helena Special Investments | Series A |
| Fortius Ventures | Series A |
| CS Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 48% MoM to 3.9K.
- Apr 1, 2026
Partnered with a majority of top 10 multinational pharmaceutical companies.
Vivodyne Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivodyne's valuation, stock price, and market status.